Reports Q3 revenue $24.1M, consensus $21.31M.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on NKTR:
- Nektar Therapeutics Reports Third Quarter 2023 Financial Results
- NKTR Earnings this Week: How Will it Perform?
- Nektar presents new responder data for rezpegaldesleukin
- Nektar enters into new clinical study collaboration with CBMG
- Nektar announces ‘promising’ data from Phase 1b study of Rezpegaldesleukin
